Munker R, Miller C W, Berenson J, Dreazen O, Koeffler H P
Medizinische Klinik III, Klinikum Grosshadern, München, Fed Rep of Germany.
Nouv Rev Fr Hematol (1978). 1989;31(1):39-43.
We established a B lymphocyte line from bone marrow cultures of a patient with Philadelphia chromosome (Ph1) positive chronic myelogenous leukemia. The cell line (MB) is positive for Ph1 and has the phenotype of mature B lymphocytes transformed by the Epstein-Barr virus (EBV). When DNA was isolated and hybridized to specific cDNA probes, a rearranged immunoglobulin gene and EBV-sequences were detected. On Western blots of cell extracts, the novel fusion protein (P 210) was demonstrated with antisera against bcr and v-abl proteins. These results confirm the concept that B lymphocytes in CML can be involved in the malignant clone and demonstrate that these B cells express the fusion protein.
我们从一名费城染色体(Ph1)阳性慢性粒细胞白血病患者的骨髓培养物中建立了一个B淋巴细胞系。该细胞系(MB)Ph1呈阳性,具有被爱泼斯坦-巴尔病毒(EBV)转化的成熟B淋巴细胞的表型。当分离DNA并与特异性cDNA探针杂交时,检测到重排的免疫球蛋白基因和EBV序列。在细胞提取物的蛋白质免疫印迹法中,用针对bcr和v-abl蛋白的抗血清证实了新型融合蛋白(P 210)的存在。这些结果证实了慢性粒细胞白血病中的B淋巴细胞可参与恶性克隆这一概念,并证明这些B细胞表达融合蛋白。